Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
11.01
-0.17 (-1.52%)
Dec 20, 2024, 4:00 PM EST - Market closed
Delcath Systems Revenue
Delcath Systems had revenue of $11.20M in the quarter ending September 30, 2024, with 2,480.65% growth. This brings the company's revenue in the last twelve months to $22.64M, up 945.91% year-over-year. In the year 2023, Delcath Systems had annual revenue of $2.07M, down -24.05%.
Revenue (ttm)
$22.64M
Revenue Growth
+945.91%
P/S Ratio
12.76
Revenue / Employee
$297,947
Employees
76
Market Cap
352.03M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.07M | -654.00K | -24.05% |
Dec 31, 2022 | 2.72M | -836.00K | -23.52% |
Dec 31, 2021 | 3.56M | 1.91M | 115.98% |
Dec 31, 2020 | 1.65M | 66.00K | 4.18% |
Dec 31, 2019 | 1.58M | -1.83M | -53.62% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
ZimVie | 451.29M |
AngioDynamics | 292.73M |
Y-mAbs Therapeutics | 84.55M |
REGENXBIO | 84.33M |
Absci | 4.21M |
DCTH News
- 19 days ago - Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer - Business Wire
- 4 weeks ago - Delcath Begins Platform Expansion With Two Phase 2 Trials - Seeking Alpha
- 4 weeks ago - Delcath Systems: Q3 Earnings Reveal HEPZATO KIT And CHEMOSAT Growth - Seeking Alpha
- 6 weeks ago - Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Delcath Systems Reports Third Quarter 2024 Results and Business Highlights - Business Wire
- 7 weeks ago - Delcath Systems to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Delcath Systems to Host Third Quarter 2024 Earnings Call - Business Wire
- 2 months ago - Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results - Business Wire